Public attitudes about pharmaceutical companies have improved significantly during the pandemic, and litigators are gearing up to deal with that trend in the courtroom.

Some attorneys who file drug defect suits expect that drug company lawyers will seek to bask in the glow of their newfound public esteem at upcoming pharmaceutical trials.